"Herzlich willkommen im Evangelischen Waldkrankenhaus Spandau Unsere Behandlungsschwerpunkte liegen in den Bereichen Erkrankungen und Verletzungen des Bewegungsapparats, der Onkologie, Gefäßmedizin, Altersmedizin sowie Innere Medizin. Unser Geburtszentrum ist in Kooperation mit der Neonatologie als Perinatalzentrum Level I anerkannt. So können auch Frauen mit Mehrlingsschwangerschaften und sehr zeitige Frühgeburten medizinisch exzellent versorgt werden. Unsere Klinik für Kinder- und Jugendmedizin wurde in seiner Qualität ausgezeichnet („Ausgezeichnet für Kinder“). Besonders spezialisiert sind unsere Orthopäd*innen im Zentrum für Kinder- und Jugendorthopädie auf die Behandlung angeborener Fehlbildungen der Extremitäten."

During the past decade, Evangelisches Waldkrankenhaus Spandau conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Evangelisches Waldkrankenhaus Spandau" #1 sponsor was "Charite University, Berlin, Germany" with 2 trials, followed by "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 2 trials sponsored, "Waldkrankenhaus Protestant Hospital, Spandau" with 2 trials sponsored, "German CLL Study Group" with 1 trials sponsored and "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Evangelisches Waldkrankenhaus Spandau" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Austrian Breast Cancer Study Group" with 1 trials as a collaborator, "BARMER" with 1 trials as a collaborator, "Biofortis, Merieux NutriSciences" with 1 trials as a collaborator and "ClinAssess GmbH" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Evangelisches Waldkrankenhaus Spandau" are "Ovarian Cancer" (3 trials), "Cholangiocarcinoma" (2 trials), "Gallbladder Cancer" (2 trials), "Hepatocellular Cancer" (2 trials) and "Oesophageal Cancer" (2 trials). Many other conditions were trialed in "Evangelisches Waldkrankenhaus Spandau" in a lesser frequency.

Most popular intervention types in "Evangelisches Waldkrankenhaus Spandau" are "Drug" (11 trials), "Other" (4 trials), "Radiation" (3 trials), "Behavioral" (2 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil" (1 trials), "5FU, 2400 mg/m2" (1 trials), "5FU, 250 mg/m2" (1 trials), "5FU; 2400 mg/m2" (1 trials) and "Ara-C, Mitoxantrone, Daunorubicin, Thioguanin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Evangelisches Waldkrankenhaus Spandau" are 15 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Evangelisches Waldkrankenhaus Spandau". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Evangelisches Waldkrankenhaus Spandau, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Evangelisches Waldkrankenhaus Spandau, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".